Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance

Status: Active_not_recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study evaluates whether using small financial incentives increases patient compliance with nationally-mandated living kidney donor follow-up at 6-months, 1-year, and 2-years after donation. Half of participants will receive a financial incentive (mailed gift card) after completing required follow-up activities (brief questionnaire and lab draw), while the other half will be asked to complete the required follow-up activities but will not receive a financial incentive (current standard of care).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults (≥18 years)

• Have undergone live donor nephrectomy at the Johns Hopkins Hospital Comprehensive Transplant Center (MDJH) or the University of Maryland Medical Center Transplant Center (MDUM).

Locations
United States
Maryland
The Johns Hopkins Hospital Comprehensive Transplant Center
Baltimore
University of Maryland Medical Center Transplant Center
Baltimore
Time Frame
Start Date: 2017-03-22
Completion Date: 2026-08-01
Participants
Target number of participants: 320
Treatments
No_intervention: Standard of Care
Participants in the control arm will be instructed to attend required follow-up as is standard of care, but will not receive a financial incentive.
Experimental: Financial Incentive
Up to three gift cards to a major online retailer will be mailed to participants assigned to the intervention arm after complete (i.e. all components addressed) and timely (i.e. within the policy-defined follow-up period) submission of follow-up data at each 6-month, 1-year, and 2-year follow-up visit.
Authors
Macey L. Henderson, Joseph Scalea
Related Therapeutic Areas
Sponsors
Collaborators: University of Maryland, Baltimore, The Living Legacy Foundation
Leads: Johns Hopkins University

This content was sourced from clinicaltrials.gov